Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells

A highly selective inhibition of de novo pyrimidine synthesis in the intact cell has been demonstrated by the action of N-(phosphonacetyl)-L-aspartate (PALA), a transition-state analog inhibitor of the reaction catalyzed by asparate transcarbamylase. The effect of pyrimidine deprivation induced by t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 1977-09, Vol.37 (9), p.3080-3087
Hauptverfasser: Tsuboi, K K, Edmunds, N H, Kwong, L K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3087
container_issue 9
container_start_page 3080
container_title Cancer research (Chicago, Ill.)
container_volume 37
creator Tsuboi, K K
Edmunds, N H
Kwong, L K
description A highly selective inhibition of de novo pyrimidine synthesis in the intact cell has been demonstrated by the action of N-(phosphonacetyl)-L-aspartate (PALA), a transition-state analog inhibitor of the reaction catalyzed by asparate transcarbamylase. The effect of pyrimidine deprivation induced by this agent on the viability and survival of human normal (WI-38) and colonic cancer cells (HT-29) was examined. The PALA-treated, pyrimidine-deprived cells failed to grow but demonstrated a normal rate of glucose utilization with impaired glycogen synthesis. Pyrimidine deprivation and lack of cell growth were maintained long after PALA removal. Growth inhibition of HT-29 cells by PALA was found to reflect an apparent steady state between newly formed and dying cells induced by limited pyrimidine availability. The highly selective nature of PALA action was confirmed by the ability of an exogenous source of pyrimidine to restore the normal growth pattern of the cell. Significant antitumor activity of PALA was found against a transplantable colonic tumor (line 26) carried in mice.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_83957132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>83957132</sourcerecordid><originalsourceid>FETCH-LOGICAL-h238t-14dd81de3e07cde5d56e09c1f748629aea7b9cbb5d76854e1e02c5797e20c96c3</originalsourceid><addsrcrecordid>eNotkEtPwzAQhH3gVQr_gINP3CI5cRw7R1TxkipxAM6RHxuyVWIXOwHl35PSnkYrfTOa2TOyYoypTJSyuCLXKe2WU-RMXJILpcqqEiuye4ce7Ig_QNF3aHDE4Glo6X6OOKBDD9RgSLMfO0iYqPaOQtsuHrqA-xh6bCHq_4SvGH7H7uC2oQ8eLbXaW4jUQt-nG3Le6j7B7UnX5PPp8WPzkm3fnl83D9usK7gas7x0TuUOODBpHQgnKmC1zVtZqqqoNWhpamuMcLJSooQcWGGFrCUUzNaV5Wtyf8xdyn1PkMZmwHRooD2EKTWK10LmvFjAuxM4mQFcs18W6zg3x9_wP6LtYb8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83957132</pqid></control><display><type>article</type><title>Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Tsuboi, K K ; Edmunds, N H ; Kwong, L K</creator><creatorcontrib>Tsuboi, K K ; Edmunds, N H ; Kwong, L K</creatorcontrib><description>A highly selective inhibition of de novo pyrimidine synthesis in the intact cell has been demonstrated by the action of N-(phosphonacetyl)-L-aspartate (PALA), a transition-state analog inhibitor of the reaction catalyzed by asparate transcarbamylase. The effect of pyrimidine deprivation induced by this agent on the viability and survival of human normal (WI-38) and colonic cancer cells (HT-29) was examined. The PALA-treated, pyrimidine-deprived cells failed to grow but demonstrated a normal rate of glucose utilization with impaired glycogen synthesis. Pyrimidine deprivation and lack of cell growth were maintained long after PALA removal. Growth inhibition of HT-29 cells by PALA was found to reflect an apparent steady state between newly formed and dying cells induced by limited pyrimidine availability. The highly selective nature of PALA action was confirmed by the ability of an exogenous source of pyrimidine to restore the normal growth pattern of the cell. Significant antitumor activity of PALA was found against a transplantable colonic tumor (line 26) carried in mice.</description><identifier>ISSN: 0008-5472</identifier><identifier>PMID: 884665</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Aspartic Acid - administration &amp; dosage ; Aspartic Acid - analogs &amp; derivatives ; Aspartic Acid - pharmacology ; Cell Division - drug effects ; Cells, Cultured ; Colonic Neoplasms - drug therapy ; Colonic Neoplasms - metabolism ; Colonic Neoplasms - pathology ; DNA, Neoplasm - biosynthesis ; Humans ; Kinetics ; Mice ; Mice, Inbred BALB C ; Neoplasm Transplantation ; Neoplasms, Experimental - drug therapy ; Neoplasms, Experimental - metabolism ; Neoplasms, Experimental - pathology ; Organophosphorus Compounds - administration &amp; dosage ; Organophosphorus Compounds - pharmacology ; Pyrimidines - biosynthesis ; Pyrimidines - pharmacology ; Transplantation, Isogeneic ; Uridine - pharmacology</subject><ispartof>Cancer research (Chicago, Ill.), 1977-09, Vol.37 (9), p.3080-3087</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/884665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsuboi, K K</creatorcontrib><creatorcontrib>Edmunds, N H</creatorcontrib><creatorcontrib>Kwong, L K</creatorcontrib><title>Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>A highly selective inhibition of de novo pyrimidine synthesis in the intact cell has been demonstrated by the action of N-(phosphonacetyl)-L-aspartate (PALA), a transition-state analog inhibitor of the reaction catalyzed by asparate transcarbamylase. The effect of pyrimidine deprivation induced by this agent on the viability and survival of human normal (WI-38) and colonic cancer cells (HT-29) was examined. The PALA-treated, pyrimidine-deprived cells failed to grow but demonstrated a normal rate of glucose utilization with impaired glycogen synthesis. Pyrimidine deprivation and lack of cell growth were maintained long after PALA removal. Growth inhibition of HT-29 cells by PALA was found to reflect an apparent steady state between newly formed and dying cells induced by limited pyrimidine availability. The highly selective nature of PALA action was confirmed by the ability of an exogenous source of pyrimidine to restore the normal growth pattern of the cell. Significant antitumor activity of PALA was found against a transplantable colonic tumor (line 26) carried in mice.</description><subject>Animals</subject><subject>Aspartic Acid - administration &amp; dosage</subject><subject>Aspartic Acid - analogs &amp; derivatives</subject><subject>Aspartic Acid - pharmacology</subject><subject>Cell Division - drug effects</subject><subject>Cells, Cultured</subject><subject>Colonic Neoplasms - drug therapy</subject><subject>Colonic Neoplasms - metabolism</subject><subject>Colonic Neoplasms - pathology</subject><subject>DNA, Neoplasm - biosynthesis</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neoplasm Transplantation</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Neoplasms, Experimental - metabolism</subject><subject>Neoplasms, Experimental - pathology</subject><subject>Organophosphorus Compounds - administration &amp; dosage</subject><subject>Organophosphorus Compounds - pharmacology</subject><subject>Pyrimidines - biosynthesis</subject><subject>Pyrimidines - pharmacology</subject><subject>Transplantation, Isogeneic</subject><subject>Uridine - pharmacology</subject><issn>0008-5472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1977</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotkEtPwzAQhH3gVQr_gINP3CI5cRw7R1TxkipxAM6RHxuyVWIXOwHl35PSnkYrfTOa2TOyYoypTJSyuCLXKe2WU-RMXJILpcqqEiuye4ce7Ig_QNF3aHDE4Glo6X6OOKBDD9RgSLMfO0iYqPaOQtsuHrqA-xh6bCHq_4SvGH7H7uC2oQ8eLbXaW4jUQt-nG3Le6j7B7UnX5PPp8WPzkm3fnl83D9usK7gas7x0TuUOODBpHQgnKmC1zVtZqqqoNWhpamuMcLJSooQcWGGFrCUUzNaV5Wtyf8xdyn1PkMZmwHRooD2EKTWK10LmvFjAuxM4mQFcs18W6zg3x9_wP6LtYb8</recordid><startdate>197709</startdate><enddate>197709</enddate><creator>Tsuboi, K K</creator><creator>Edmunds, N H</creator><creator>Kwong, L K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>197709</creationdate><title>Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells</title><author>Tsuboi, K K ; Edmunds, N H ; Kwong, L K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h238t-14dd81de3e07cde5d56e09c1f748629aea7b9cbb5d76854e1e02c5797e20c96c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1977</creationdate><topic>Animals</topic><topic>Aspartic Acid - administration &amp; dosage</topic><topic>Aspartic Acid - analogs &amp; derivatives</topic><topic>Aspartic Acid - pharmacology</topic><topic>Cell Division - drug effects</topic><topic>Cells, Cultured</topic><topic>Colonic Neoplasms - drug therapy</topic><topic>Colonic Neoplasms - metabolism</topic><topic>Colonic Neoplasms - pathology</topic><topic>DNA, Neoplasm - biosynthesis</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neoplasm Transplantation</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Neoplasms, Experimental - metabolism</topic><topic>Neoplasms, Experimental - pathology</topic><topic>Organophosphorus Compounds - administration &amp; dosage</topic><topic>Organophosphorus Compounds - pharmacology</topic><topic>Pyrimidines - biosynthesis</topic><topic>Pyrimidines - pharmacology</topic><topic>Transplantation, Isogeneic</topic><topic>Uridine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsuboi, K K</creatorcontrib><creatorcontrib>Edmunds, N H</creatorcontrib><creatorcontrib>Kwong, L K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsuboi, K K</au><au>Edmunds, N H</au><au>Kwong, L K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1977-09</date><risdate>1977</risdate><volume>37</volume><issue>9</issue><spage>3080</spage><epage>3087</epage><pages>3080-3087</pages><issn>0008-5472</issn><abstract>A highly selective inhibition of de novo pyrimidine synthesis in the intact cell has been demonstrated by the action of N-(phosphonacetyl)-L-aspartate (PALA), a transition-state analog inhibitor of the reaction catalyzed by asparate transcarbamylase. The effect of pyrimidine deprivation induced by this agent on the viability and survival of human normal (WI-38) and colonic cancer cells (HT-29) was examined. The PALA-treated, pyrimidine-deprived cells failed to grow but demonstrated a normal rate of glucose utilization with impaired glycogen synthesis. Pyrimidine deprivation and lack of cell growth were maintained long after PALA removal. Growth inhibition of HT-29 cells by PALA was found to reflect an apparent steady state between newly formed and dying cells induced by limited pyrimidine availability. The highly selective nature of PALA action was confirmed by the ability of an exogenous source of pyrimidine to restore the normal growth pattern of the cell. Significant antitumor activity of PALA was found against a transplantable colonic tumor (line 26) carried in mice.</abstract><cop>United States</cop><pmid>884665</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1977-09, Vol.37 (9), p.3080-3087
issn 0008-5472
language eng
recordid cdi_proquest_miscellaneous_83957132
source MEDLINE; American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Aspartic Acid - administration & dosage
Aspartic Acid - analogs & derivatives
Aspartic Acid - pharmacology
Cell Division - drug effects
Cells, Cultured
Colonic Neoplasms - drug therapy
Colonic Neoplasms - metabolism
Colonic Neoplasms - pathology
DNA, Neoplasm - biosynthesis
Humans
Kinetics
Mice
Mice, Inbred BALB C
Neoplasm Transplantation
Neoplasms, Experimental - drug therapy
Neoplasms, Experimental - metabolism
Neoplasms, Experimental - pathology
Organophosphorus Compounds - administration & dosage
Organophosphorus Compounds - pharmacology
Pyrimidines - biosynthesis
Pyrimidines - pharmacology
Transplantation, Isogeneic
Uridine - pharmacology
title Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A42%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20inhibition%20of%20pyrimidine%20biosynthesis%20and%20effect%20on%20proliferative%20growth%20of%20colonic%20cancer%20cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Tsuboi,%20K%20K&rft.date=1977-09&rft.volume=37&rft.issue=9&rft.spage=3080&rft.epage=3087&rft.pages=3080-3087&rft.issn=0008-5472&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E83957132%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=83957132&rft_id=info:pmid/884665&rfr_iscdi=true